Recent work has uncovered roles for inositide signalling pathways downstream of phospholipase C activation and inositol 1,4,5-trisphosphate in the regulation of nuclear processes including gene expression, mRNA export and DNA metabolism. The identifi cation of several IPKs (inositol polyphosphate kinases) has renewed interest in the cellular roles of inositol tetra-, penta-, hexa-and pyro-phosphates. Discoveries of inositide receptors and novel mechanisms of inositide action have provided important insights into how such messengers couple to nuclear machinery. In this chapter, we discuss the IPK family members and the nuclear processes that their inositide products regulate.
Introduction
Inositides are essential second messengers found in all eukaryotes that regulate specifi c biological processes. Of the eleven enantiomers of inositol, only D-myo-inositol serves as a biologically active precursor to numerous inositides, a term used to defi ne the collection of both water-soluble IPs (inositol phosphates) and inositol lipids or PIPs (phosphoinositides). The individual and combinatorial phosphorylation of D-myo-inositol, defi ned by the axial D-2 position hydroxy group and fi ve remaining equatorial hydroxy groups, enables 63 theoretical unique derivatives of IPs. Furthermore, attachment of the inositol headgroup to glycerol-based lipids and the discovery of PP-IPs (inositol pyrophosphates) creates further diversity amongst this ensemble of intracellular messengers. The vast majority of cellular stimulants have been shown to activate RTKs (receptor
Nuclear synthesis and function of PIPs
Within the past 25 years, the demonstration that PIPs, their kinases and PLC isozymes are compartmentalized within the nucleus has raised an intriguing possibility that inositides are involved in the regulation of nuclear processes. Smith and Wells [6] found that purifi ed nuclear envelopes that were incubated with labelled ATP had the capacity to generate a number of PI (phosphoinositide) species; indicating the nuclear presence of both PIs and PI kinases. A fraction of these components are retained in detergent-treated nuclei, suggesting that they may be associated with a non-membrane, perhaps proteinaceous component of the nucleus [7] . Subsequent studies have shown that specifi c isoforms of PI kinases are found in the nucleus throughout eukaryotes [8] [9] [10] . Furthermore, the nuclear localization and nucleo-cytoplasmic shuttling of PLC isozymes indicates that pools of nuclear PIP 2 (phosphatidylinositol 4,5-bisphosphate) may be locally initiating IP 3 and DAG (diacylglycerol) signalling pathways [11] [12] [13] . Some evidence indicates that PIPs are involved in the regulation of nuclear functions such as transcription and pre-mRNA splicing [14] . Antibodies that are thought to recognize PIP 2 in fi xed cells show partial association with nuclear speckles that co-localize with RNA processing machinery [15] . Additionally, PIP receptors have been identifi ed including nuclear hormone receptors, histones and chromatin remodelling complexes [16] [17] [18] [19] [20] .
Conceptually the notion of nuclear PIP signalling challenges the dogma that PLC acts solely at the plasma membrane. Future studies in this area will need to address the specifi c mechanisms through which nuclear kinases, lipases and phosphatases are locally activated. One example providing clues into this mechanism come from studies showing that nuclear PLC-␤1 is selectively activated by insulin-like growth factor 1 [11, 21] . Topologically, how do agonists acting at the plasma membrane activate PIP metabolic machinery, i.e. PLC in the nucleus? Is nuclear IP 3 generated? Studies suggesting that IP 3 receptors localize to the inner nuclear membrane and mediate nuclear calcium release provide support for this hypothesis [22] . Alternatively it is possible that IP 3 is generated in the cytosol and is able to diffuse through the nuclear pore complex. Equally important will be the demonstration that in living cells nuclear PIP 2 exists and is metabolized in response to agonists. Paradoxically, it remains unclear why cells expressing a PIP 2 reporter, GFP (green fl uorescent protein)-PH (PLC␦), do not illuminate the nuclear envelope. It is possible that nuclear PIP 2 pools are: (i) present in such low abundance that they are not detected by GFP-based reporters; (ii) physically masked; and/or (iii) diffuse throughout the nucleus and are not part of the nuclear bilayer, a notion supported by biochemical studies indicating that there is non-membrane-associated nuclear PIP 2 [7, 23, 24] . Of interest, the Downes laboratory has shown by quantitative immunoelectron microscopy methods that a signifi cant amount of PIP 3 is present in the nuclear matrix region and is not associated with the nuclear membrane [24a] . Thus the fi eld is now poised to resolve these questions and determine mechanisms of nuclear lipid signalling pathways.
Nuclear IPKs and IPSs (inositol pyrophosphate synthases)
Signifi cant progress in understanding the molecular basis for IP synthesis has come from the cloning and characterization of IPKs (see Figures 1 and 2) . A genetically economical route for IP 6 synthesis in budding yeast, Saccharomyces cerevisiae, has been identifi ed through the merger of metabolomic studies and a genetic screen that identifi ed factors involved in mRNA export [25] . The pathway is lipid-dependent based on observations that deletion of the sole yeast PI-specifi c phospholipase, Plc1, results in a failure to produce IP 6 , whereas overexpression of Plc1 up-regulates IP 6 synthesis over 20-fold [25] . Pulse-chase metabolic analysis of Plc1 overexpressing cells showed that IP 3 was generated fi rst and then sequentially phosphorylated to IP 6 . Biochemical studies in fi ssion and budding yeast from the Michell and Downes laboratories described a pathway of IP 3 conversion into IP 6 via 6-, 3-and 2-kinase activities respectively [26 -28] . Metabolic labelling of three mutant strains of yeast identifi ed to be involved in Gle1-mediated mRNA export, one of which was plc1, resulted in the molecular identifi cation of the 2-kinase, designated Ipk1 [25] and subsequently the 6-and 3-kinase activities were found to be encoded by a single gene product, designated Ipk2/ Arg82/ArgRIII [29] . Contemporaneously, Saiardi and Snyder identifi ed yeast Ipk2/Arg82/ArgRIII as an IP 3 multi-kinase activity with sequence similarity to a family of IP 6 kinases [30] and then along with Shears found it functioned as an IP 3 kinase in yeast cells [31] . Thus in budding yeast, a pathway for PLC-dependent conversion of IP 3 into IP 6 simply occurs through Ipk2 and Ipk1.
In addition to the IPKs, budding yeast have at least two distinct IPS activities which generate branch points that emerge from the IP 3 to IP 6 core pathway [30, 32, 33] . It is noted that originally these activities were designated IP 6 kinases; however, since some utilize IP 4 and IP 5 as substrates it is suggested that IPS may be a more general nomenclature. Kcs1, originally identifi ed as a second-site suppressor of protein kinase C mutants, functions as an IPS that generates high-energy PP-IPs, PP-IP 4 and PP-IP 5 , from IP 5 and IP 6 respectively [30, 33, 34] . A second activity, designated Ips1, exists in yeast cells defi cient in kcs1 [33] ; however its molecular identity has not been reported. Interestingly, Kcs1 also functions as an intrinsic IP 3 3-kinase activity, or regulator thereof, based on in vivo metabolomic analysis showing that it initiates a novel messenger pathway in yeast [32] .
The IPK and IPS gene products are conserved in eukaryotes from yeast to humans. Studies in plants, fruit fl ies and mammals demonstrate that Ipk2, also known as IPMK (inositol polyphosphate multi-kinase), and Ipk1 are required for IP 6 synthesis [36] [37] [38] [39] [40] [41] [42] . That said, in some eukaryotes the complexity of these pathways is greater (as Figure 2 illustrates) and alternative routes of IP 6 synthesis occur [3] [4] [5] 36, 40, [43] [44] [45] [46] . For example, two additional IPKs function to regulate IP 6 synthesis: (i) an IP3K (IP 3 3-kinase), and (ii) a 5/6-K (IP 3 5/6/1-kinase) ( Figure 1 ) [47] [48] [49] [50] . Interestingly, neither of these gene products is found in the Saccharomyces cerevisiae genome, and Arabidopsis has a 5/6-K but does not appear to harbour the IP3K gene product. Mice have three IP3K isoforms and individual deletions do not appear to alter IP 5 production; however, IP 6 levels were not reported [51] . In Drosophila, RNAi (RNA interference) of one or both of the IP3K isoforms paradoxically increases IP 6 production, possibly through expanding IP 3 pools which are then utilized by dmIpk2 to generate more IP 6 [37] . Disruption of 5/6-K results in decreased IP 6 synthesis in maize (lpa mutants) and human cells [40, 45, 52] .
Subcellular localization studies of IPKs and IPSs indicate that, in part, they function in the nucleus. Ipk2 from multiple species localizes primarily within the nucleus [29, 36, 37, 42, 53, 54] . Yeast Ipk1 localizes to the nuclear envelope [25] and yeast Plc1 and mammalian PLC isoforms ␤ and ␦ undergo nucleo-cytoplasmic shuttling. Kcs1 and mammalian IPSs (referred to in these papers as IP6Ks) have been found to localize to both the nucleus and cytoplasm [34, 55] . The IP3K and 5/6-K primarily localize to the cytoplasm.
What remains unclear is whether or not these kinases and synthases are required to be nuclear to execute their proper function. Studies in which Ipk1 is artifi cially targeted to the plasma membrane still synthesize IP 6 [56] . Heterologous expression of Arabidopsis thaliana, Drosophila melanogaster and Rattus norvegicus IPK2 gene products in ipk2-defi cient yeast restore IP 4 / IP 5 synthesis activity [36] [37] [38] . Likewise, yeast Ipk2 is functional in Rat-1 cells despite what appears to be primarily cytoplasmic localization [36] . These data indicate that a specifi c localization does not appear to be required for metabolic function; however, a cautionary note remains that in these studies heterologous proteins were overexpressed and quantitative functional assays have not been adequately performed. Furthermore, the small size and rapid diffusion of soluble IP molecules throughout the cell make it diffi cult to reconcile exactly wherethe substrates for the IPKs and IPSs are generated. Importantly, the ability to image the spatio-temporal generation and function of these messengers in real-time is critical to resolving these issues. Development of quantitative functional readouts of the nuclear processes regulated by IPs will also be necessary in future studies.
IP regulators of transcription and chromatin remodelling
The regulation of gene expression by inositides is a theme that has emerged from the past two decades of research. Among the fi rst connections of inositol signalling to transcriptional control were those made by the Henry laboratory through studies of yeast INO1 [57] [58] [59] . The complex regulation of Ino1 expression relies on several cis-acting elements that link to sensing lipid and small molecules within the cell. Additionally, Crabtree and co-workers [20] observed that PIP 2 increases recruitment of the mammalian BAF chromatin remodelling complex to the nuclear matrix. Subsequent studies found that PIP 2 binds directly to the BAF complex and increases its association with stable polymerized actin [19] .
A link between soluble IP production and gene expression has come from genetic and biochemical studies of the yeast transcriptional regulator Arg82, which reveal that it encodes an IP 3 kinase, designated Ipk2 [29] . Subsequently, Ipk2/Arg82 was identifi ed as a regulator of chromatin remodelling through studies of expression of yeast PHO5 [60] and of nitrogen responsive gene regulation [61] . As outlined in the section above, yeast Ipk2/Arg82 functions as a 6-/3-kinase capable of converting IP 3 into IP 5 [29, 31] . Ipk2/Arg82 is conditionally essential for survival of yeast when grown on arginine or ornithine, but not glutamate, as the sole nitrogen source [29, 62, 63] . Ipk2/Arg82 is one of four components (Mcm1, Arg80, Arg81 and Arg82) of the ArgR-Mcm1 complex required for an arginine-specifi c transcriptional response [64] . Ipk2/ Arg82 directly associates with Mcm1, a MADS box DNA-binding protein [65] . It has been proposed that ArgR-Mcm1 controls the transcriptional activation of arginine catabolic gene products and repression of arginine anabolic pathway members, thereby allowing cells to reprogramme nitrogen production under certain nutritional limitations. In response to arginine, Ipk2/Arg82 is recruited to active regions of transcription as measured by ChIP (chromatin immunoprecipitation) assays [66] .
Ipk2/Arg82 appears to regulate gene expression through both kinase 'dependent' and 'independent' mechanisms. The assembly of ArgR-Mcm1 protein complexes on 'arginine box' site-specifi c DNA promoter elements in vitro requires Ipk2 protein but not its kinase activity [29] . In contrast, kinase activity and production of IPs through PLC are required for proper activation of ArgR-Mcm1 transcription complexes as determined through a phenotypic assay looking for cell growth on minimal medium supplemented with arginine or ornithine as the sole nitrogen source [29] . Based on these data, a two-component model is justifi ed in which both protein and production of IPs are required for ArgR-Mcm1 assembly and function [29] . This model is challenged by data from Dubois and colleagues [67] describing that Ipk2 kinase activity and IP production are not required for transcriptional regulation of arginine metabolism, and suggest that a protein determinant on Ipk2 is needed for stabilization of Mcm1 and/or ArgR-Mcm1 complexes [61, 65] . This idea remains controversial and is refuted by a recent study which reports that expression of Drosophila melanogaster Ipk2 fully rescues the ability of ipk2 null yeast to grow on ornithine [32] . Drosophila and S. cerevisiae Ipk2 share less than 20% similarity and residues implicated for Mcm1 stability are not conserved, yet they generate the same IP products and its expression in yeast serves as an inositol 'add back' experiment [37] . This suggested that production of IPs are required and suffi cient for proper regulation of arginine metabolism and bypass the requirement for the 'kinase-independent' protein component [32] . However, further work is required to demonstrate how transcription can occur in the absence of the complex-forming ability of Ipk2 protein. It has also been recently suggested that mammalian and yeast Ipk2 harbour PIP 2 3-kinase activity and that this lipid kinase function is important for transcriptional control of some but not all genes [69] . A number of studies now point to a more general role for IPs in transcriptional regulation as they are required for the expression of genes that are not involved in the arginine response (see two examples below) [29, 60, 61, 70] . A transcriptional role for PP-IPs was also proposed because kcs1 mutants also display transcriptional defects [61] .
Recent studies have provided evidence of mechanistically how Ipk2 products, such as IP 4 and IP 5 , regulate gene expression. Higher-order chromatin structures are precisely regulated to control access of nuclear machinery to DNA. De-repression of gene expression can occur when chromatin remodelling complexes mobilize nucleosomes from promoter regions and allow access of regulatory factors and general transcriptional machinery. The O'Shea laboratory observed that transcriptional regulation by IPs occurs through the regulation of chromatin remodelling. They identifi ed Ipk2 in a genetic screen for factors that are involved in the regulation of transcription at the PHO5 promoter [60] . Expression of Pho5 was repressed in strains containing plc1 or ipk2 mutations because chromatin remodelling complexes were unable to mobilize nucleosomes from the promoter. Using ChIP experiments, Ino80 and SWI/SNF chromatin remodelling complexes were identifi ed as the mediators of nucleosome mobilization at the PHO5 promoter. Further, their recruitment to promoters was impaired in strains that lacked IP 4 and IP 5 synthesis. As a result, transcription factors could not access the promoter and transcription of the Pho5 was blocked. These results indicate that IP 4 and IP 5 play a positive role in recruiting Ino80 and SWI/SNF complexes to specifi c promoters.
Shen and co-workers [70] proposed a molecular basis for the action of the IPs on the chromatin remodelling complexes. The authors used an in vitro nucleosome mobilization assay to measure the activities of chromatin remodelling complexes in the presence of different IPs. They found that several classes of complexes were either stimulated or inhibited in their ability to mobilize nucleosomes. IP 6 inhibited nucleosome mobilization by the NURF, INO80 and ISW2 complexes, potentially through inhibition of their ATPase activities. In contrast, IP 6 did not inhibit nucleosome mobilization by the SWI/ SNF complex, whereas IP 4 and IP 5 were stimulatory. The authors demonstrated that transcription of the INO1 gene was fully repressed in plc1 and ipk2 mutants and partially repressed in ipk1 mutants. This suggests that IP 4 , IP 5 and IP 6 are required for proper transcriptional regulation of the Ino1 expression, possibly by directly targeting the chromatin remodelling complexes themselves.
Another example of the potential convergence of lipid and soluble inositides in gene expression came from a recently discovered family of PHD (plant homeodomain) fi nger-containing proteins that interact with PIPs [17] . PHD fi ngers are implicated in transcriptional regulation by interacting with or modifying chromatin, in part, through the regulation of histone acetylation [71] . Gozani and co-workers [17] demonstrated that a PHD fi nger family member ING2 interacts with lipids both in vitro and in vivo. The signifi cance of this interaction in transcriptional responses was identifi ed as disruption of lipid signalling could perturb ING2 function in vivo. These data have defi ned a novel class of nuclear lipid-binding domains and implicate the PIPs in mediating their function. Interestingly, there is genetic evidence linking a PIP kinase and PHD domains to transcription. A yeast two-hybrid screen to identify proteins that associate with a Drosophila melanogaster PHD-containing protein, ASH2, identifi ed a putative PIP kinase called SKTL (skittles) [16] . Functional ASH2 was required for SKTL recruitment to chromatin and sktl mutant chromosomes showed a dramatic increase in histone H1 phosphorylation. A functional signifi cance of the interaction was proposed as the authors found that sktl mutants could increase the instance of an ash2 homeotic transformation phenotype. Of signifi cant interest are recent reports of the crystal structure of the ING2 PHD fi nger bound to trimethylated lysine residues of histone tails (H3K4me3) [72] [73] [74] [75] . This raises several new possibilities regarding how IP and PIP molecules may regulate chromatin remodelling through the histone code hypothesis. What remains to be determined is whether or not IP/PIP and H3K4me3 binding to PHD fi ngers occur through the same pocket, overlapping or completely distinct sites.
IP regulators of mRNA export
The fi rst genetic evidence that implicated IPs in nuclear functions was the discovery that they are required for effi cient mRNA export from the nucleus [25] . A genetic screen was designed to gain insight into the function of GLE1, a factor thought to function as a mediator between splicing and nuclear export of poly(A) + RNA. Plc1, Ipk2 and Ipk1 were identifi ed as factors that are synthetically lethal with GLE1. Mutations in all three genes resulted in a common failure to both generate IP 6 and export mRNA from the nucleus. Based on these data, IP 6 was proposed as a mediator of mRNA export. To further defi ne the step at which IP 6 -mediated mRNA export occurs, Miller et al. [56] identifi ed genes that were synthetically lethal with an ipk1-null strain. Ipk1 showed genetic interaction with a subset of genes at the nuclear pore that had been previously tied to GLE1 function. Several nucleoporins were identifi ed that reside on the cytoplasmic face of the nuclear pore and the authors speculated that the IP 6 site of action might reside there. Recent work by two different groups reveals that this hypothesis was correct as GLE1, a resident protein on the cytoplasmic face of the nuclear pore was found to interact directly with IP 6 [76, 77] . Interestingly, the GLE1/ IP 6 complex was found to recruit and activate the activity of the DExE/H-box ATPase Dbp5, a component that is required for mRNA export. Further, when Ipk1 is expressed with a STE2 tag that localizes it to the plasma membrane it is able to rescue the growth defect of a gle1/ipk1 double mutant. Taken together these results suggest that cytoplasmic production of IP 6 is suffi cient to stimulate mRNA export from the nucleus by binding GLE1 and activating the ATPase activity of DBP5.
Studies by Majerus and co-workers implicated IPs in the regulation of mRNA export in humans [78, 79] . The Salmonella Dublin virulence factor SopB is an inositol phosphatase that hydrolyses a wide range of IP and PI species [78] . When SopB was expressed in human cells, IP levels, including IP 6 , were almost completely eliminated [79] . Coincident with the loss of cellular IPs, mRNA was found to accumulate in the nucleus. Further studies will be required to attribute this export defect to a loss of IP 6 .
IP regulators of DNA metabolism
There are several lines of evidence to indicate that inositides function as mediators of DNA metabolism through, homologous recombination, NHEJ (non-homologous end joining), regulation of telomere length and DNA repair. The yeast inositol pyrophosphate inositol kinase (KCS1) was originally cloned as a suppressor of a hyper-recombination phenotype conferred by a mutant pkc1 allele [80] . The suppression was later attributed to PP-IP production through Kcs1 because a kinase-dead mutant could not suppress the pkc1 allele [34] . The mechanism through which the PP-IPs mediate recombination may be general because KCS1 appeared to regulate all of the possible mechanisms tested. Another connection of IPs to DNA repair comes from identifi cation of Ipk2 as a dosage suppressor of rad53-null and mec1 mutant yeast [81] , both Rad53 and Mec1 function to monitor genome integrity checkpoints.
A role for IP 6 is proposed as a positive regulator of NHEJ in mammalian cells. The components that are required for NHEJ include the Ku70/80 heterodimer that binds to DNA ends and a DNA-dependent protein kinase catalytic subunit (DNA-PK cs ) that shares signifi cant homology with the PI3K family. Ku recruits DNA-PK to the DNA and the break is repaired by a DNA ligase IV. An in vitro assay reveals that IP 6 could activate the DNA-PK cs /Ku holoenzyme [82] . The IP 6 interaction appeared to be mediated through its direct binding Ku [83, 84] . Further experiments found that Ku underwent differential proteolysis depending on the presence of IP 6 , suggesting that it mediates a conformational change in Ku [83] . A potential link to cellular IP production and Ku was made using photobleaching experiments [85] . Cells that were partially depleted of IPs had correlative reduced mobility of GFP-Ku. The authors hypothesized that an IP 6 -mediated conformational change caused Ku to become dissociated from its binding partners and diffuse through the nucleus. Studies in yeast found that IP 6 is unable to bind to yeast Ku and end joining is not defective in vivo when IP synthesis is disrupted [33, 83] . Further studies are required to demonstrate that, in metazoans, IP 6 mediates DNA end joining in vivo.
York and co-workers [33] recently identifi ed an additional role for IPs in DNA maintenance through the regulation of telomere length in yeast. They found that plc1, ipk2 and kcs1 mutants have longer telomeres as compared with wild-type cells. These data implicate PP-IP 4 as a negative regulator of telomere length. Consistent with this hypothesis, mutant cells with increased levels of PP-IP 4 have shorter telomeres. Further, the authors demonstrate that PP-IP 4 production is epistatic with the PI3K-related protein kinase Tel1 in the regulation of telomere length. These data are supported by Saiardi and co-workers [86] who also found a role for PP-IPs in the regulation of telomere length through TEL1. The mechanistic basis for inositol pyrophosphate regulation to telomere length remains an important area of study, especially related to direct receptors that mediate the effect.
Modes of inositol signal transduction
Critical to our understanding of how IPs regulate cellular processes is the identifi cation of the IP receptors that transduce their signals (Figure 3) . Recent work has revealed diverse mechanisms through which inositides function and explains why classical approaches to identify IP receptors have been largely unsuccessful. Second messengers are classically thought to act by allosterically regulating their target proteins. IP 3 is a prototypical example of this as it binds to and modulates the conformation of the IP 3 receptor to stimulate the release of calcium from intracellular stores [87] .
A second mode of protein regulation was recently discovered that points to a homoeostatic role for IPs [88] . Bass and co-workers solved the structure of the catalytic domain of the RNA adenosine deaminase, ADAR2, and unexpectedly found IP 6 buried deep within the catalytic core. IP 6 is required for maintaining the structure of ADAR2 and enzyme purifi ed from yeast mutants that lacked IP 6 were inactive.
A third mechanism involves a translocation/competition mode in which inositol lipid-binding proteins translocate to membranes and this relocalization may be infl uenced by competing soluble IPs. Hirose et al. [89] demonstrated that the PH domain of PLC-␦1 could be competed off PIP 2 by IP 3 both in vitro and in vivo. These data suggest a mechanism whereby the spatial localization of a protein can be regulated through interplay between PI and IP signalling pathways. Another example of this was described by Lou et al. [90] who found that competition for a PH domain between PIP 3 and PP-IP 5 formed a regulatory mechanism for Dictyostelium chemotaxis.
A fourth mode has been put forward indicating that PP-IPs function as high-energy phosphate donors for protein phosphorylation. Saiardi and co-workers [91] reported that PP-IPs non-enzymatically phosphorylated proteins in vitro. They found that proteins are phosphorylated through donation of the ␤-phosphate of certain PP-IP species in cellular extracts from diverse eukaryotic species. Interestingly, the protein recipient required a 'priming' step, the nature of which is not clear. One of the PP-IP phosphorylated proteins identifi ed is yeast NSR1, a nucleolar protein that is differentially phosphorylated in kcs1 mutant strains that are defective for PP-IP synthesis. Although these results point to a novel mode of cellular signalling by PP-IPs, the fi eld awaits studies that demonstrate a functional signifi cance in cells.
Concluding remarks
Much progress has been made in the identifi cation of nuclear processes regulated by IPs (Figure 4 ). There still remains many mechanistic questions as to how and where this regulation occurs. How are such pathways activated? Where are such pathways activated? The dogma and much of the experimental evidence indicates that the bulk of PIP 2 synthesis and hydrolysis occurs at the plasma membrane, so why are the IPKs nuclear? Why does PLC shuttle in and out of the nucleus? Is there a pool of PIP 2 in the nucleus? Genetic and biochemical evidence says the answer is yes; however, the relative percentage of the cellular total is unclear. What are the receptors of nuclear IPs and PP-IPs?
The evolution of the IPK and IPS gene products is of signifi cant interest. Ipk2/IPMK and IPS/IP6K family members are conserved from yeast to humans. In contrast, the ITPK (IP 3 3-kinase) branch is observed in selected metazoans Figure 3 Modes of inositide signalling. The classical mode of inositode signalling is through the allosteric regulation of target proteins, for example IP 3 -stimulated release of calcium through allosteric regulation of the IP 3 receptor. A second mode of regulation has been identifi ed recently in which the IP molecule is a structural cofactor required for the proper folding of the protein -the crystal structure of the deaminase, ADAR2, revealed IP 6 bound at the core of the protein fold [88] . A third mode of regulation is through the interplay between the inositol lipids and water-soluble inositide headgroups (PIP and IPs). PIP-bound proteins are spatially restricted and are released into the cytoplasm through a competitive interaction with soluble IP messengers. Finally, a fourth mode has been possibly identifi ed in which IP effector proteins may be regulated through protein phosphorylation by PP-IPs. Recent in vitro studies indicate that the ␤-phosphate is donated to 'primed' protein substrates; however proof that PP-IP 5 -dependent protein phosphorylation occurs in cells awaits further study. and not in plants or fungi. This may imply that Ipk2 and IPS activities evolved fi rst among the group. Furthermore, since certain Ipk2 proteins exhibit diphosphoryl synthase and PIP 2 3-kinase activities [43, 69, 92] , it is possible that Ipk2 was the earliest ancestor capable of promiscuous synthesis of several IP and PIP species in a genetically economical fashion. Why would nature utilize an enzyme that lacks the exquisite specifi city? Given that many of the inositidemetabolizing enzymes are highly selective, this promiscuity is intriguing. An interesting possibility is that Ipk2/IPMK specifi city may be regulated/restricted through (i) post-translational modifi cation, (ii) receptor activation, and/or (iii) association with regulatory proteins.
An interesting evolutionary aspect of comparing yeast and metazoan IP signalling is that yeast do not appear to have IP 3 -mediated calcium release nor does DAG appear to regulate protein kinase C. In contrast the Ipk2/IPMK, Ipk1 and IPS/IP6K pathways are conserved from yeast to humans. So it is a little surprising that the canonical 'textbook' aspects of inositide signalling pathways are not conserved through evolution. This raises a few provocative questions. Is the primordial role of PLC-induced inositide signalling to produce IP 3 , which is then converted by IPK and IPS activities to regulate nuclear processes? Is Figure 4 Inositide regulation of nuclear function. Higher phosphorylated IPs are generated through the activities of IPKs localized to the nucleus and/ or cytoplasm. Genetic and biochemical studies reveal diverse nuclear events that are regulated by specifi c IP messengers. These include processes such as mRNA export, gene expression, chromatin remodelling, DNA metabolism, telomere maintenance and protein phosphorylation.
there an order to the events executed by Ipk2, Ipk1 and IPS activities? As calcium and PKC signalling evolved in metazoans, one could ask, did these messengers displace the need for IP-mediated regulation of nuclear processes? Recent studies would argue no as they have demonstrated an essential role for IP 5 , IP 6 and possibly PP-IP production in metazoan development [3] [4] [5] , thereby providing clues that higher IP pathways are not vestigial in metazoans. The studies of higher IP regulation have raised many new questions which are of signifi cant interest in the signalling fi elds.
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